Advertisement
Advertisement

IKT

IKT logo

Inhibikase Therapeutics, Inc. Common Stock

2.06
USD
Sponsored
+0.07
+3.52%
May 08, 15:58 UTC -4
Closed
exchange

After-Market

2.06

0.00
+0.24%

Inhibikase Therapeutics, Inc. Common Stock Profile

About

Inhibikase Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing therapeutics for Parkinson's disease and related disorders. The company operates principally in Boston, Massachusetts. Inhibikase Therapeutics Inc. is headquartered in Atlanta, Georgia.

Info & Links

CEO

Mark Iwicki

Headquarters

1000 N. WEST STREET, SUITE 1200
WILMINGTON, DE 19801, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.inhibikase.com

Auditor

CohnReznick LLP

Share holders

27

Employees

35

Inhibikase Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

272.65M

Enterprise Value

133.43M

Enterprise Value/EBITDA(ttm)

-2.57

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.73

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-46.90%

Return on Invested Capital(ttm)

-52.07%

Return on Assets(ttm)

-43.48%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-51.91M

Net Income Available to Common(ttm)

-48.26M

Diluted EPS(ttm)

-0.48

Share Statistics

Beta (5Y Monthly)

0.86

52-Week Change

-1.90%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

132.03M

Dividend Yield

0.00%

Float4

122.39M

% Held by Insiders

7.30%

% Held by Institutions

3.81%

Balance Sheet

Total Cash(mrq)

178.76M

Total Cash Per Share(mrq)

1.35

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

21.70%

Quick Ratio(mrq)

21.70%

Book Value Per Share(mrq)

1.31

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.28

Free Cash Flow(ytd)

-27.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement